Aernoud Fiolet

399 List of publications LIST OF PUBLICATIONS Traets MJM, Nijhuis RHT, Morré SA, Ouburg S, Remij JA, Blok BA, de Laat B, Jong E, Herder GJM, Fiolet ATL, Verweij S. A genetic variation in TIRAP gene is associated with mortality in COVID-19. PLOS ONE . 2022;17:e0260897. Opstal TSJ, van Broekhoven A, Fiolet ATL, Mosterd A, Eikelboom JW, Nidorf SM, Thompson PL, Budgeon CA, Bax WA, Tijssen JGP, El Messaoudi S, Cornel JH. Long-term efficacy of colchicine in patients with chronic coronary artery disease. Insights from LoDoCo2. Circulation . 2021. In print. Opstal TSJ, Fiolet ATL, van Broekhoven A, Mosterd A, Eikelboom JW, Nidorf SM, Thompson PL, Duyvendak M, van Eck JWM, van Beek EA, den Hartog F, Budgeon CA, Bax WA, Tijssen JGP, El Messaoudi S, Cornel JH. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome. Journal of the American College of Cardiology . 2021;78:859–66. Fiolet ATL, Silvis MJM, Opstal TSJ, Bax WA. Inflammatie bij coronairlijden: van begrip naar behandeling. Focus Vasculair . 2021;6(2);64-75 Fiolet ATL, Opstal TSJ, Silvis MJM, Cornel JH, Mosterd A. Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail. Netherlands Heart Journal . 2021. In print. van der Burg M, Balder JW, van de Brand JJG, van Gulik S, Fiolet ATL. Non- bacterial thrombotic endocarditis. Small abnormalities with great aftermaths. Nederlands Tijdschrift Voor Geneeskunde . 2021. In print Silvis MJM, Fiolet ATL, Opstal TSJ, Dekker M, Suquilanda D, Zivkovic M, Duyvendak M, The SHK, Timmers L, Bax WA. Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy. Atherosclerosis . 2021;334:93–100. Silvis MJM, van Hout GPJ, Fiolet ATL, Dekker M, Bosch L, van Nieuwburg MMJ, Visser J, Jansen MS, Timmers L, de Kleijn DPV. Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned. BMC Cardiovascular Disorders . 2021;21:1–9.